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Abstract
Background: Mesenchymal stem cells (MSCs) harvested from cadaveric tissues represent a promising approach
for regenerative medicine. To date, no study has investigated whether viable MSCs could survive in cadaveric
tissues from tendon or ligament up to 72 hours of post-mortem. The purpose of the present work was to find
out if viable MSCs could survive in cadaveric tissues from adult equine ligaments up to 72 hours of post-mortem,
and to assess their ability (i) to remain in an undifferentiated state and (ii) to divide and proliferate in the absence
of any specific stimulus.
Methods: MSCs were isolated from equine cadaver (EC) suspensory ligaments within 48–72 hours of post-
mortem. They were evaluated for viability, proliferation, capacity for tri-lineage differentiation, expression of cell
surface markers (CD90, CD105, CD73, CD45), pluripotent transcription factor (OCT-4), stage-specific embryonic
antigen-1 (SSEA-1), neuron-specific class III beta-tubulin (TUJ-1), and glial fibrillary acidic protein (GFAP). As well,
they were characterized by transmission electron microscope (TEM).
Results: EC-MSCs were successfully isolated and maintained for 20 passages with high cell viability and
proliferation. Phase contrast microscopy revealed that cells with fibroblast-like appearance were predominant
in the culture. Differentiation assays proved that EC-MSCs are able to differentiate towards mesodermal lineages
(osteogenic, adipogenic, chondrogenic). Flow cytometry analysis demonstrated that EC-MSCs expressed CD90,
CD105, and CD73, while being negative for the leukocyte common antigen CD45. Immunofluorescence analysis
showed a high percentage of positive cells for OCT-4 and SSEA-1. Surprisingly, in absence of any stimuli, some
adherent cells closely resembling neuronal and glial morphology were also observed. Interestingly, our results
revealed that approximately 15 % of the cell populations were TUJ-1 positive, whereas GFAP expression was
detected in only a few cells. Furthermore, TEM analysis confirmed the stemness of EC-MSCs and identified some
cells with a typical neuronal morphology.
Conclusions: Our findings raise the prospect that the tissues harvested from equine ligaments up to 72 hours
of post-mortem represent an available reservoir of specific stem cells. EC-MSCs could be a promising alternative
source for tissue engineering and stem cell therapy in equine medicine.
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Background
In equine clinical medicine, adult mesenchymal stem cells
(MSCs) are commonly used for regeneration of injured
tissues [1–3]. MSCs have been found in many tissues
wherein quiescent stem cells can become active following
injury, migrating into the damaged area to perform repair-
ing functions [4]. MSCs from bone marrow (BM-MSCs)
are most generally considered as the universal source in
spite of the presence of some detrimental features, such as
pain, morbidity and extremely low amounts (0.01–0.001 %)
of cells at harvest. Furthermore, a high degree of viral infec-
tion and a decreased incidence of proliferation/differenti-
ation with increased aging have been recorded [5–7].
Additionally, it is associated with pneumopericardium in
the donor horse secondary to a sternal bone marrow aspir-
ation [8]. As an alternative, adipose-derived mesenchymal
stem cells (AD-MSCs) have also been used for regenerative
therapies. Although relatively easier to recover, nevertheless
the current evidence shows that the AD-MSCs appear less
effective than BM-MSCs in differentiation assays and gen-
erate a higher risk of donor-site morbidity in comparison
with BM-MSCs [9]. These hindrances justify an investiga-
tion into other sources that could be used for therapeutic
benefit [10]. In this field, tendon-derived stem cells
(TDSCs) appear to be very promising in equine regenera-
tive medicine [11]. Actually, TDSCs have many advantages
compared to BM-MSCs, such as more clonogenicity, a
higher rate of proliferation, and multi-lineage differentiation
potential. Moreover, the use of TDSCs decreases the risk
for ectopic bone formation as reported with BM-MSC [12].
Usually, stem cells are isolated from biopsies per-
formed on embryonic, foetal or adult living hosts. The
restricted number of donors, and the limited amount of
material obtained from biopsies are the two major limit-
ing factors of this approach. In this context, stem cells
harvested from cadaveric tissues represent a potential
source for a multitude of even rare stem cells. This strat-
egy should be explored and could generate new insights
and provide future treatment strategies in regenerative
medicine [13–17].
Taking these observations into account, fundamental
and clinical research studies are now required to investi-
gate whether MSCs isolated from equine cadavers are
suitable, abundant, and readily available to be used in
future clinical applications. The present work is the first,
in both animal and human, to show that tissues har-
vested from cadaveric ligaments up to 72 hours post-




Four cadaveric forelimbs, received within 48–72 hours
post-mortem (from horses 18–20 years old) were used
for this study. Horses were euthanised for reasons other
than suspensory ligament (SL) injury and had no previ-
ous clinical history of forelimb lameness. SLs were con-
firmed free of any damage following examination of the
tissues both macroscopically and microscopically.
Consent for cadaver use was obtained from all horse
owners, and all study procedures were approved by the
Ethical Committee for Animal Use of the Faculty of
Veterinary Medicine, University of Liege, Liege, Belgium.
Cell isolation and culture
Tissue was harvested from the cores of SL branches.
Three pieces (approximately 30–50 g) of tissue were re-
covered with a scalpel and forceps, cut into small pieces
and processed immediately under aseptic conditions.
Subsequently, the fragments were placed in plastic tubes
(Corning Life Sciences, Corning, NY, USA) containing
0.2 % (w/v) collagenase A (Roche, Mannheim, Germany)
in phosphate buffered saline (PBS, Lonza, Verviers,
Belgium) supplemented with 1 % penicillin–streptomycin
(Gibco, Invitrogen Corporation, Carlsbad, CA, USA), and
1 % fungizone (Gibco). They were incubated for 18 h at
37 °C in a humidified atmosphere containing 5.0 % CO2.
After incubation, the remaining tissue pieces were re-
moved and the digestion solution was filtered using a 40-
μm-pore sized nylon cell strainer (BD Falcon, Franklin
Lakes, NJ, USA). After digestion, the solution was centri-
fuged at 1000 rpm for 5 min and the supernatant dis-
charged. The cell pellet was washed twice with PBS
(Lonza), then resuspended and cultured in Dulbecco's
modified Eagle's minimal essential medium (DMEM) with
4.5 g/L glucose (Lonza) supplemented with 10 % foetal
bovine serum (FBS, Gibco), 1 % penicillin–streptomycin,
1 % fungizone and 1 % L-glutamine (Gibco) at 37 °C in a
humidified atmosphere containing 5.0 % CO2. The
medium was changed every three days until cell cultures
reached confluence. Before passaging, cells were washed
twice with PBS (Lonza), detached by using 0.05 % (w/v)
trypsin in 0.1 % (w/v) ethylenediaminetetraacetic acid
(EDTA, Lonza) and were either used in experiments or
replated (1/3) in 25 cm2 culture flasks. At passage zero
(P-0) cells were plated onto plastic culture dishes (Greiner
Bio One, Frickenhausen, Germany) and from P1 to P20 in
culture flasks (Nunclon, Roskilde, Denmark).
Viability, population doubling, and freezing
Isolated EC-MSCs were cultured until subconfluent
(70-80 %) and, at each passage, the percentage of cell
viability was determined by mixing the cell suspension
with 1:1 ratio of Trypan blue solution (Sigma Aldrich,
St Louis, Mo., USA) for 2 min. Then, the cells were
subsequently resuspended and viable cells (Trypan blue
negative cells) were counted using a haemocytometer
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microchamber under a light microscope (Olympus
IX71, Olympus, Tokyo, Japan).
The proliferative capacity of EC-MSCs was evaluated
from P1 to P20 by Trypan blue exclusion assay. The
cumulative population doubling (CPD) and population
doubling time (PDT) were calculated using the following
formulas:
CPD ¼ 3:33X log10 N=N0ð Þ
PDT ¼ CT=CPD
Where N0 is the initial cell seeding number, N is the
cell harvest number and CT is the culture time.
For freezing, cells were suspended in freezing medium
containing DMEM (Lonza) supplemented with 20 % FBS
(Gibco) and 10 % dimethyl sulfoxide (DMSO, Sigma
Aldrich). Samples were stored at −80 °C overnight and
then placed in liquid nitrogen (−196 °C) for long-term
storage. The thawing process involved placing the cryo-
vial in a water bath at 37 °C to be thawed, and cryopro-
tectant was diluted immediately.
Differentiation assay
Multipotent differentiation capability of EC-MSCs was
assessed at P3. Cells intended to be used for osteogenic
and adipogenic differentiation were seeded into 12-well
plates at a density of 5 × 103 cells/cm2 and 1 × 104 cells/
cm2, respectively. These cells were then incubated at
37 °C in a humidified atmosphere of 95 % air and 5 %
CO2. After 24 h, the culture media were replaced by the
differentiation media StemPro osteogenesis and StemPro
adipogenesis (Gibco) and changed every three days.
Non-induced EC-MSCs were cultured for the same time
in growth medium as control. The osteogenic differenti-
ation was assessed by Alizarin Red S staining for cal-
cium deposits in extracellular matrix (Sigma-Aldrich).
Adipogenic differentiation was checked by Oil Red O
staining (Sigma-Aldrich) for the presence of lipid drop-
lets in the cytoplasm.
For chondrogenic differentiation, a micromass culture
method was achieved by seeding 5-μL droplets of 1.6 × 107
viable cells/mL solution into the centre of 12-well plates.
After 2 h under high humidity conditions, differentiation
medium StemPro chondrogenesis (Gibco) was gently added
and incubated at 37 °C with 5 % CO2. The differentiation
medium was changed every three days. Non-induced EC-
MSCs were cultured for the same time in growth medium
as control. The chondrogenic differentiation was assessed
by Alcian Blue staining (Sigma-Aldrich) for proteoglycan-
rich extracellular matrix detection.
Flow cytometric characterization
Flow cytometry was used to characterize the surface
markers of the cultured EC-MSCs. Cells from P3 were
dissociated from the growth flask using Hanks'-Based,
Enzyme Free, Cell Dissociation Buffer (Gibco), and re-
suspended in DMEM (Lonza) containing 10 % FBS
(Gibco). Samples were counted, centrifuged, and resus-
pended in PBS containing 10 % FBS. The cells were
transferred to Eppendorf tubes at 5 × 105 cells per 1 mL,
washed twice with PBS containing 10 % FBS, and incu-
bated for 1 h at room temperature in the dark with the
following antibodies: PE-conjugated mouse anti-human
CD73 (Clone AD2, BD Pharmingen), PE-conjugated
mouse anti-human CD90 (Clone 5E10, BD Pharmingen,
Erembodegem, Belgium), PE-conjugated mouse anti-
human CD105 (Clone 1G2, Beckman Coulter, Marseille,
France), and FITC-conjugated rat anti-mouse CD45
(Clone 30-F11, eBioscience, Halle-Zoersel, Belgium).
The samples were then washed twice with PBS, stained
with 1 μL of Fixable Viability Dye eFluor® 450 per 1 mL
of cells, vortexed, incubated for 30 min at 4 °C in the
dark, and washed with PBS before analysing with flow
cytometry. Unlabelled cells were used as the negative
control for detection of autofluorescence.
Cell cultures for immunofluorescence
Cells were plated on uncoated glass coverslips using a cul-
ture medium composed of DMEM (Lonza) with 1 % peni-
cillin–streptomycin, 1 % fungizone, 1 % L-glutamine and
10 % FBS (Gibco) and then incubated for two to three
days in an atmosphere of humidified 5 % CO2 in air.
Fluorescent cell labelling
Before immunostaining, cells were fixed with 4 % (w/v)
paraformaldehyde (Sigma Aldrich) in PBS (pH 7.4), at room
temperature for 20 min, then permeabilised with 0.1 % Tri-
ton X-100 (Sigma Aldrich) in PBS at room temperature for
30 min. Non-specific binding was blocked for 1 h in 10 %
goat serum (Sigma Aldrich) in PBS at room temperature.
Cells were then incubated overnight at 4 °C with the follow-
ing primary antibodies: rabbit anti-OCT-4 (1:200, Abcam,
Cambridge, UK), mouse anti-SSEA- 1 (1:50, Santa Cruz
Biotechnology, Santa Cruz, CA, USA), mouse anti-TUJ-1
(1:1500, Babco, Richmond, CA, USA), rabbit anti-TUJ-1
(1:1000, Covance, Cumberland, VA, USA), and rabbit anti-
GFAP (1:1000, Dako, Glostrup, Denmark). After washing
with PBS, the cells were incubated at room temperature for
1 h 30 min in the dark with appropriate fluorochrome-
conjugated secondary antibodies: anti-rabbit Alexa Fluor
488 or 568 (1: 4000, Invitrogen, Grand Island, NY, USA),
anti-mouse FITC (1:400, Santa Cruz Biotechnology), and
anti-mouse Alexa Fluor 568 (1:4000, Molecular Probes, Lei-
den, Netherlands). Coverslips were washed with PBS,
stained with 1:200 dilutions of 4',6-diamidino-2-phenylin-
dole for 10 min (DAPI, Life Technologies, Carlsbad, CA,
USA) for nuclear staining, and then mounted in fluores-
cence mounting medium and analysed under an Olympus
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IX71 microscope. Images were acquired using the micro-
scope equipped with fluorescent optics, and (USB 2.0
CAMERA) software. The specificity of the antibodies was
tested using an isotype control antibody and negative con-
trols were obtained by omitting the primary antibody.
Immunofluorescence staining quantification
To quantify the percentage of positively stained cells for
OCT-4, SSEA-1, TUJ-1, and GFAP, the number of posi-
tive cells for each marker, in ten random fields of view,
were counted and compared to the cell number positive
for DAPI. An average value per marker was calculated.
The percentages reported in this study refer to an aver-
age value (mean ± SD) of at least three experiments for
each marker at P 3 and P20.
Transmission electron microscopy (TEM) observation
Adherent cells were pre-fixed in the culture plate with
2.5 % (w/v) glutaraldehyde (Sigma Aldrich) solution in
0.1 M cacodylate buffer (Sigma Aldrich) pH 7.4 for 2 min
at room temperature. Subsequently, cells were rinsed in the
same buffer, scraped from the plate and centrifuged. The
pellet was post-fixed for 30 min with a mixture of 1 % os-
mium tetroxide (OsO4) and 1.5 % potassium ferrocyanide
(K4(Fe(CN)6)) in a 0.1 M cacodylate buffer (pH 7.4),
dehydrated in a graded series of alcohols, and then embed-
ded in EPON 812 (Fluka, Buchs, Switzerland) according to
standard procedures. The resin specimen blocks were
trimmed, ultrathin sections of selected areas were cut and
mounted on copper grids, then contrasted with 1 % (w/v)
uranyl acetate before examination with a Zeiss EM910
transmission electron microscope (Zeiss, Nanterre, France).
Results
Mesenchymal stem cells isolation, culture and
morphological analysis
Equine cadaver mesenchymal stem cells (EC-MSCs)
were isolated from equine SL within 48–72 hours post-
mortem. EC-MSCs were successfully expanded in vitro
and maintained for 20 passages. Phase contrast micros-
copy of seeded cells revealed that cells adhered to plates
after 48 h of the primary culture initiation. In our basic
culture medium, cells at P0 were shown to be morpho-
logically homogeneous fibroblast-like cells (Fig. 1a).
From P1 to P20, cells with fibroblast-like appearance
were the predominant population in the culture. Never-
theless, at P2, some adherent cells of different shape or
size were distinguishable. Their cell bodies were spher-
ical or oval with or without thin cytoplasmic extensions
(Fig. 1b). Spherical cells without processes were free
Fig. 1 Phase contrast images of cultured EC-MSCs. Homogeneous fibroblast-like cells (spindle-shaped in appearance) at P0 (a); among
fibroblast-like cells, some adherent cells with a different shape (spherical or oval) and size were distinguishable at P2. Insert: a spherical
cell body with thin cytoplasmic extensions (b). Spherical cells without processes were free floating in the medium, whereas cells with
neuronal- and glial-like morphology with extending processes were firmly adherent to the bottom of the flasks at P3 (c). Cells also showed
unipolar, bipolar or multipolar extensions at P3 (d). Bars, 50 μm. EC-MSCs equine cadaver mesenchymal stem cells
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floating in the medium, whereas cells closely resembling
neuronal and glial morphology with extended processes
were firmly adherent to the bottom of the flasks (Fig. 1c).
Other cells exhibiting unipolar, bipolar and multipolar ex-
tensions were also observed (Fig. 1d).
Viability, population doubling and freezing
At each passage, cell viability analysis using Trypan blue
assay revealed that the viability was usually greater than
96 %. During the period extending from P1 to P20, a
high level of proliferation was recorded. The mean
doubling time of the EC-MSCs in P1 was 23.5 ± 4.2 h
and remained almost constant up to P20. After freezing
in liquid nitrogen, the cells retained their ability to pro-
liferate under the same culture conditions.
Differentiation into osteocytes, adipocytes and chondrocytes
The multipotency of EC-MSCs was confirmed by tri-
lineage differentiation assays. The differentiation of EC-
MSCs towards osteogenic, adipogenic and chondrogenic
lineages was shown after the 10th, 12th, and 15th day,
respectively. Osteogenic differentiation was confirmed
by positive Alizarin Red S staining of extracellular cal-
cium deposits (Fig. 2a). Adipogenic differentiation was
detected by the accumulation of intracellular lipid
droplets into the cytoplasm using Oil Red O staining
(Fig. 2b). Chondrogenic differentiation was confirmed
by positive Alcian Blue staining, indicating proteogly-
cans deposition (Fig. 2c).
Flow cytometric characterization
Fixable Viability Dye eFluor 450 distinguished between
living and dead cells. A high percentage of viable cells
(86.84 %) was seen and dead cells were excluded from
the analysis. Flow cytometric analysis revealed that
EC-MSCs were positive for CD90 (96.3 %) and CD105
(64.31 %), showed low expression of CD73 (23.09 %),
and were negative for the leukocyte common antigen
CD45 (Fig. 3).
Fig. 2 Tri-lineage differentiation potential of EC-MSC at P3. Extracellular calcium deposits stained with Alizarin Red S showed the differentiation
of EC-MSC into the osteoblast lineage, whereas no calcium deposits were observed in non-induced cells (a). The accumulation of intracytoplasmic
lipid droplets stained with Oil Red O indicated the adipogenic differentiation of EC-MSC, whereas no lipid droplets were observed in non-induced
cells (b). Positive Alcian Blue staining of proteoglycan production confirmed the chondrogenic differentiation of EC-MSC, as compared to the
absence of staining of control cells (c). Bars, 200 μm. EC-MSC equine cadaver mesenchymal stem cell
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Immunofluorescence staining and phenotypic
characterization
Expression of pluripotency markers The stemness of
cultured EC-MSCs was evaluated at P3 and P20 by using
two markers, the pluripotent transcription factor (OCT-
4) and the surface-based pluripotent marker (SSEA-1).
OCT-4 immunofluorescence staining showed a clear
nuclear localization. A high percentage of cells (Table 1)
identified by DAPI staining expressed this marker. As
illustrated, a high percentage of cells (Table 1) also dem-
onstrated surface localization for SSEA-1(Fig. 4a; not
shown for P20).
Expression of neuronal and glial markers To assess
the neuronal- and glial-like phenotypes of the cultured
EC-MSCs, cells pre-labelled with DAPI staining, were
analysed for expression of neuronal (TUJ-1) and glial
(GFAP) specific markers at P1, P3 and P 20. Immuno-
fluorescence microscopic analysis did not reveal any
TUJ-1+ or GFAP+ cells at P1. On the contrary, approxi-
mately 15–16 % (Table 2) of the cell populations were
TUJ-1-positive at P 3 and P 20 with a fibrillar cytoplas-
mic staining. In addition, GFAP expression has been
shown in the cytoplasm and cytoplasmic extensions in a
small number of cells (Table 2) at P3 and P20 (Fig. 4b;
not shown for P20). Furthermore, TUJ-1 expression was
evident in the cells negative for OCT-4 and displaying a
neuronal-like morphology; generally they were pyramidal
containing numerous thin neurite-like processes. The
nucleus appeared to be round-to-oval in shape, centrally
located where it occupied one half to one third of the
cytoplasm area (Fig. 4c).
Ultrastructural characterization (TEM)
Ultrastructural analysis revealed that the EC-MSCs are
homogeneous cell populations at P1. Cells had large
nuclei with a prominent nucleolus, and an abundant
amount of euchromatin. Small pseudopodia-like pro-
cesses around the cell periphery were also observed
(Fig. 5a). Organelles, such as dilated rough endoplasmic
reticulum (Fig. 5b) and Golgi complexes (Fig. 5c) were
present in cytoplasm. In addition, tight junctions were
observed between these cells (Fig. 5d). However, some
cells at P3 and P20 appeared to have outgrowing exten-
sions (Fig. 5e) containing bundles of microtubules,
aligned parallel to their long axis (Fig. 5f ), endoplasmic
reticulum, neurofilaments and vesicles (Fig. 5g). More-
over, residual bodies (lipofuscin pigment granules) were
also visible within the cytoplasm of these cells (Fig. 5h).
Discussion
Mesenchymal stem cells (MSCs) have immense potential
in tissue engineering and are commonly used in equine
clinical medicine [2, 3]. The possibility that cadavers
may represent, for tissue maintenance and regeneration,
an alternative source of stem cells, is very exciting. Trad-
itionally, it was thought that 48 hours after death, the
presence of these stem cells in a necrotic microenviron-
ment led them to lose their utility and potential benefits
for experimental and clinical applications [13]. Actually,
while the differentiated cells die within two days after
death, the MSCs reside in their hypoxic tissue niche in a
state of quiescence or dormancy, and survive by adapt-
ing to a low rate of oxygen consumption with a slow
Fig. 3 Flow cytometric analysis of cell-surface antigen expressions on cultured EC-MSCs. EC-MSCs were analysed at P3 for the cell surface markers
CD90, CD73, CD105, and CD45. EC-MSCs showed high expression for CD90 (96.3 %), moderate expression for CD105 (64.31 %), and low expression
for CD73 (23.09 %) while were negative for the leukocyte common antigen CD45. EC-MSCs equine cadaver mesenchymal stem cells
Table 1 Expression of pluripotent markers in EC-MSCs
Marker Passage
P3 P20
OCT-4 86.6 ± 5.2 79.1 ± 8.2
SSEA-1 79.3 ± 0.5 77.3 ± 5.6
OCT-4 pluripotent transcription factor, SSEA-1 stage-specific
embryonic antigen-1
The percentages refer to an average value (mean ± SD) of at least 3
experiments for each marker at P3 and P20
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metabolism and deactivated transcription [18, 19]. Con-
sistently, anoxia and a lack of nutrients participate in the
positive selection of more robust and undifferentiated
stem cells [17]. The use of cadaveric materials would
prevent the need for foetal, embryonic or healthy
living donor sources that may help to avoid serious
ethical considerations in regenerative medicine appli-
cations [13].
To the best of our knowledge, this work is the first, in
both animal and human, to show that it is indeed pos-
sible to isolate viable MSCs from cadaveric ligament up
to 72 hours post-mortem. In the current study, samples
were taken from the SL branches which are composed
only of dense connective tissue [20]. EC-MSCs were
successfully isolated, expanded and then maintained for
20 passages with high cell viability and proliferation. In
agreement with the International Society for Cellular
Therapy criteria for defining MSCs, the data presented
here reveal that cultured EC-MSCs display characteristic
MSC cell surface markers. They showed high expression
for CD90 (96.3 %), moderate expression for CD105
(64.31 %), and low expression for CD73 (23.09 %) while
they were negative for the leukocyte common antigen
CD45. These results are consistent with several previous
studies that have demonstrated a variable expression of
CD105 and CD73 for equine MSC [21–27]. Interest-
ingly, EC-MSCs were able to prove their tri-lineage
potential and differentiated towards osteoblast, adipocyte
and chondrocyte. Moreover, the stemness of the cultured
EC-MSCs was assessed by analysing their expression pro-
file for octamer-binding transcription factor 4 (OCT-4)
and stage-specific embryonic antigen 1 (SSEA-1). In fact,
OCT-4, a master nuclear transcriptional regulator, and
SSEA-1, a cell surface antigen, are currently associated
with undifferentiated stem cells and together play an
essential role in maintaining pluripotency and stem cell
renewal [28–31]. Previous reports in equine species
Fig. 4 Immunocytochemistry analysis of pluripotency (OCT-4 and SSEA-1), neuronal (TUJ-1) and glial (GFAP) markers in cultured EC-MSCs at P3.
High percentage of cells expressed OCT-4 and SSEA-1 (OCT-4, green; SSEA-1, green; DAPI, blue) (a). A fibrillar cytoplasmic staining was detected
with TUJ-1 while the GFAP expression was seen in both the cytoplasm and the cytoplasmic extensions of only a few cells (TUJ-1, green; GFAP,
green; DAPI, blue) (b). Analysis of TUJ-1 and OCT-4 localization showed that TUJ-1-positive cells exhibited a neuronal-like appearance and were
OCT-4 negative (TUJ-1, red; OCT-4, green; DAPI, blue) (c). Bars: 20 μm. OCT-4 pluripotent transcription factor, SSEA-1 stage-specific embryonic
antigen-1, TUJ-1 neuron-specific class III beta-tubulin, GFAP glial fibrillary acidic protein, EC-MSCs equine cadaver mesenchymal stem cells,
DAPI 4',6-diamidino-2-phenylindole




TUJ-1 15 ± 0.8 16.1 ± 7.9
GFAP 4.3 ± 0.5 5.8 ± 0.9
EC-MSCs equine cadaver mesenchymal stem cells, TUJ-1 neuron-specific class
III beta-tubulin, GFAP glial fibrillary acidic protein
The percentages refer to an average value (mean ± SD) of at least 3
experiments for each marker at P3 and P20
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demonstrated that adult MSCs derived from umbilical
cords (UCB) express OCT-4 and SSEA-1, while MSCs de-
rived from AD and BM express only OCT-4 [32, 33]. In
this study, a high number of EC-MSCs expressed OCT-4
within the nucleus, and SSEA-1 on the cell surface. These
findings confirm that a high percentage of EC-MSCs are
Fig. 5 Electron micrographs illustrating ultrastructural characteristics of EC-MSCs at P1 and neuron-like cells derived from cultured EC-MSCs at P3.
EC-MSCs at P1 have large nuclei (N), prominent nucleoli (NU), small pseudopodia-like processes at the cell periphery (arrow) (a). Dilated rough
endoplasmic reticulum (arrows) (b) and Golgi complexes (arrow) (c) were present in cytoplasm. Tight junctions were seen in the periphery (arrow)
(d). Neuron-like cells at P3 have outgrowing extensions (arrow) (e). These extensions contain bundles of microtubules, which run parallel to their
long axis (arrow) (f). Endoplasmic reticulum (arrow) and vesicles (arrowhead) (g). Residual bodies (lipofuscin pigment granules) were present within
the cytoplasm (arrow) (h). Bar in (a): 2 μm; bars in (b, c, d, f, h): 200 nm; bar in (e): 5 μm; bar in (g): 100 nm. EC-MSCs equine cadaver mesenchymal
stem cells
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naive and undifferentiated sharing ancestral or primitive
characteristics [17, 29].
Certain cytokines, growth factors and chemical in-
ducers are commonly used to differentiate MSCs into
multiple mesenchymal lineages, including osteoblasts,
chondrocytes, adipocytes, myocytes and tenocytes, as
well as hepatocytes in endoderm and neural cells in
ectoderm [34–36]. Surprisingly, in our cell culture con-
ditions, in the absence of any kind of differentiation
stimuli, some cells derived from EC-MSCs displayed a
typical neuronal and glial-like morphology. As their
expressions are regarded to be evidence of MSC predis-
position to differentiate into a neuronal lineage, neur-
onal (TUJ-1) and glial (GFAP) specific markers were
evaluated in our cultured EC-MSCs [37]. TUJ-1, a
neuron-specific class III beta-tubulin, is a major compo-
nent of neuronal microtubules. Its expression has been
considered as one of the earliest markers of neuronal
commitment in primitive neuroepithelium, as well as
essential for axon growth and guidance during normal
brain development [38, 39]. GFAP, a class III IF protein,
is found in glial cells such as astrocytes and Schwann
cells. Furthermore, its expression is seen as the hallmark
of astrocytic differentiation [40]. Interestingly, immuno-
fluorescence analysis confirmed our observations under
phase contrast microscopy, showing that approximately
15 % of the cell populations were TUJ-1-positive with a
fibrillar cytoplasmic staining among the cells displaying
neuronal-like morphology, whereas the GFAP expression
was detected in both the cytoplasm and the cytoplasmic
extensions of only a few cells. These results obtained
from immunofluorescence analysis are in line with our
TEM observations, revealing that EC-MSCs from P1 have
MSC characteristics as previously described [41–43].
Nonetheless, some of these cells exhibited ultrastructural
features characteristic of neuronal cell bodies and pro-
cesses at P3 and P20. These observations are also in
accordance with another study on ultrastructural changes
of MSCs during neuronal induction [44].
Conclusions
This study demonstrated that a viable stem cell popula-
tion can be isolated and expanded from equine cadaver
ligaments up to 72 hours post-mortem. Differentiation
assays, flow cytometry, immunofluorescence and TEM
analyses confirmed the stemness of these cells. Our re-
search may benefit the development of an advantageous
source of stem cells for regenerative medicine and cell
therapy technologies. EC-MSCs may provide a low cost
solution in ready supply for the development of novel
therapeutic strategies in horses. Although the generation
of MSCs into neuronal lineage with specific inductions
is well-documented, our findings herein indicate that
some EC-MSCs, without any specific external stimulus,
are able to spontaneously express in vitro neural and
glial markers. However, the functional recovery of these
cells should be verified. In a more specific way, indu-
cing differentiation of EC-MSCs into tenocytes would
appear to be a promising approach for the treatment of
equine tendinopathies.
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